Syracuse, NY3 Active Studies

Multiple Sclerosis Clinical Trials in Syracuse, NY

Find 3 actively recruiting multiple sclerosis clinical trials in Syracuse, NY. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
373
Enrolling

Recruiting Multiple Sclerosis Studies in Syracuse

About Multiple Sclerosis Clinical Trials in Syracuse

Multiple sclerosis (MS) is an autoimmune disease where the immune system attacks the protective covering of nerve fibers, causing communication problems between the brain and body. Symptoms vary widely and can include vision problems, fatigue, and mobility issues. Disease-modifying therapies have significantly improved outcomes.

There are currently 3 multiple sclerosis clinical trials recruiting participants in Syracuse, NY. These studies are seeking a combined 373 participants. Research is being sponsored by Hoffmann-La Roche, Janssen Research & Development, LLC, Eli Lilly and Company. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Sclerosis Clinical Trials in Syracuse — FAQ

Are there multiple sclerosis clinical trials in Syracuse?

Yes, there are 3 multiple sclerosis clinical trials currently recruiting in Syracuse, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Syracuse?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Syracuse research site will contact you about next steps.

Are clinical trials in Syracuse free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Syracuse studies also compensate for your time and travel.

What multiple sclerosis treatments are being tested?

The 3 active trials in Syracuse are testing new therapies including novel drugs, biologics, and treatment approaches for multiple sclerosis.

Data updated July 22, 2026 from ClinicalTrials.gov